A MediCom Oncology Site
This website uses cookies. By using our site you agree to our
privacy policy
Username:
Password:
Lost username/password
Create an account
Home
About Us
Membership Benefits
Clinical Advisory Board
Supporters
Awards
Site Map
Contact Us
Disclosures
Our News
Accreditation
Reference
FAQ Library
Clinical Pearls Podcasts
Newsletters
Clinical Case Snapshots
Clinical Expert Commentaries
Journal Club Library
2018 RRMM Symposium Replay
COVID-19 Resource Center
Tools
Criteria for Diagnosis
Revised International Staging System for Multiple Myeloma
CE Education
Annual Meeting Highlights
Accredited E-Newsletter Series
Practice Essentials
Targeting B-cell Maturation Antigen in Relapsed/Refractory Multiple Myeloma: New Findings in Clinical Context
Challenging Cases in RRMM Symposium Replay
Case Series
Comorbid Patients with Multiple Myeloma: Considering All the Facts in Treatment Selection
--- Archives ---
RRMM Navigating New Treatment Paradigms
Clinical Briefs
Clinical Dialogues™ in Multiple Myeloma
Clinical Discussion Series
Recognizing the Signs and Symptoms of MM in the Primary Care Setting
CE for Nurses
Resources
Live Events
Web Links
Jesus F. San Miguel, MD
Professor of Hematology
University of Salamanca
Head of the Department of Hematology
University Hospital of Salamanca
Salamanca, Spain
Last modified: April 1, 2020
Authored Items
What do I need to know about renal impairment in my patients?
Jesus F. San Miguel, MD
FAQ Library
published on
March 15, 2011
in
Comorbidities/SEs
,
Renal Impairment
What are the goals of induction therapy?
Jesus F. San Miguel, MD
FAQ Library
published on
February 16, 2010
in
Induction Therapy
,
Treatment Goals
MediCom Worldwide, Inc. Links
MedicalEd.com
|
ManagingAML.com
|
ManagingMDS.com
|
PracticalOncologist.com
|
PartnersinPancreaticCancer.com
|
ManagingLymphoma.com
|
EmergingSolutionsinPain.com
|
MediComWorldwide.com
